Background: Acute myeloid leukemia (AML) cells are characterized by non-mutated TP53, high levels of Hdm2, and frequent mutation of the Flt3 receptor tyrosine kinase. The juxtamembrane mutation of FLT3 is the strongest independent marker for disease relapse and is associated with elevated Bcl-2 protein and p53 hyper-phosphorylation in AML. DNA damage forms the basic mechanism of cancer cell eradication in current therapy of AML.
Background
Anthracyclines like daunorubicin (DNR) are used in the induction treatment of acute myeloid leukemia (AML), obtaining short time complete hematological remission for more than 65% of adult AML patients with de novo AML [1] . Successful hematological remission after only one induction cycle is a favorable prognostic parameter and is associated with decreased risk of later AML relapse [1, 2] . Induction therapy causes rapid activation of the tumor suppressor p53 followed by dominating p53-targeted gene expression in vivo [3] . A major mechanism for this p53 induction is DNA damage through anthracyclinestabilization of the DNA:topoisomerase II complex [4] , but cell death induction by anthracyclines may also involve other molecular targets independent of p53 [4] [5] [6] [7] .
Ionizing radiation (IR) is frequently used in the treatment of solid cancers, in the conditional treatment before allotransplantation of leukemia patients and in radioisotope-conjugated therapeutic antibodies directed against AML cells [8, 9] . IR and anthracyclines induce growth arrest and cell death through DNA-damage, but also involve cell membrane-related effects in regulation of apoptosis [4] [5] [6] [7] 10] . We have previously reported that AML patient cells respond with varying sensitivity to IRinduced proliferation arrest [11] , and it may therefore be of interest to determine molecular mechanisms for radioresistance in more detail.
The strongest molecular predictor for AML relapse is internal tandem duplications in the juxtamembrane domain of the receptor tyrosine kinase Flt3 (Flt3-ITD). These mutations are present in approximately one third of the patients [12] . Flt3-ITD are associated with increased DNA repair [13] , an observation suggesting that these cells are able to recover from DNA damage caused by topoisomerase II blockage and thus have a more drug-resistant phenotype. The expression of anti-apoptotic Bcl-2 protein family members is also influenced by the mutational status of Flt3 [14] . We have recently shown that a duplication of Y591 in Flt3-ITDs is associated with elevated Bcl-2 protein and hyper-phosphorylated wild type (wt) p53 in AML, proposing a mechanism for inactivation of p53 [14] .
Mcl-1 is an anti-apoptotic member of the Bcl-2 family of proteins. High levels of Mcl-1 have been detected in cells from patients with relapsed AML [15] . Therapeutic targeting of Bcl-2 family proteins seems to depend on Mcl-1 to trigger apoptosis [16] . It may therefore be of particular interest to examine the Mcl-1 modulation in DNA damage therapy.
In contrast to solid tumors, more than 90% of the AML cases comprise wild type p53 [17, 18] . On the other hand, the E3 ubiquitin ligase Hdm2 is usually strongly expressed in AML, contributing to block the growth inhibitory and pro-apoptotic effect of p53 [19] . IR induces DNA damage and rapid down regulation of Hdm2 through induction of auto-ubiquitination and subsequent proteasomal degradation [20] . Recent reports indicate that Hdm2 have important p53-independent activities, including regulation of cell membrane receptors like insulin-like growth factor (IGF) 1 receptor and β2-adrenergic receptor through ubiquitination [21] . However, it is not known whether the Flt3 receptor is regulated by Hdm2.
Concerted protein modulation of a receptor tyrosine kinase, the E3 ubiquitin ligase Hdm2 and selected Bcl-2 family members through DNA damage therapy has previously not been reported. Our study indicated that both IR and DNR induced Hdm2 protein down regulation, partly Flt3 protein elevation, and a pro-apoptotic shift in the expression of proteins in the Bcl-2 family. Flt3 and Hdm2 might have a reciprocal regulation at the protein level and FLT3 mutations could be involved in protection against IR-induced apoptosis through a persisting Mcl-1 level.
Results

Ionizing radiation induces reciprocal regulation of Flt3 and Hdm2 protein in NB4 cells
The promyelocytic cell line NB4 is characterized by mutated TP53 and non-functional p53 protein [22, 23] as well as wild type FLT3 [24] . DNA damaging 25 Gy IR of NB4 cells resulted in increased apoptosis, but no modulation of FLT3 or HDM2 mRNA was observed ( Fig. 1a,b ; left panel). Hdm2 responds to IR with protein auto-degradation [20] , and it regulates endocytosis of certain receptors like the IGF 1 receptor [25] . We examined Flt3 and Hdm2 at different time points after IR (25 Gy) and found highly significant reciprocal regulation at the protein level ( Fig.  1c ; left panel). This was accompanied by attenuation of the anti-apoptotic Mcl-1, an increase in Bax but unaltered Bcl-2 ( Fig. 1d ; left panel) and Bcl-X L (data not shown). Previous studies have shown that DNA-damaging in vivo chemotherapy of AML has no effect on MCL-1 gene induction, but rapidly induces BAX and PUMA mRNA [3] (Øyan et al., manuscript in preparation). p21 protein was not detected in NB4 cells (data not shown), and the p53 protein level was not altered after irradiation ( Fig. 1d ; left panel), reflecting its non-functional status.
Hdm2 response and stable Mcl-1 in the IR-resistant cell line MV4-11 MV4-11 is characterized by FLT3-ITD, loss of wilt type FLT3 allele, and wild type TP53 [22, 24] . MV4-11 cells were resistant to IR with regards to apoptosis induction (Fig 1a, right panel) , but responded with more than one fold increase in HDM2 mRNA (Fig. 1b) , reflecting the functional p53. The level of Hdm2 protein showed a Rapid IR-induced protein modulation of Flt3, Hdm2 and Bcl-2 family members in AML cell lines small but significant decrease after 60 minutes before an increase was detected, whereas the Flt3 level increased in response to IR and was not attenuated by the elevated HDM2 level after 180 minutes (Fig. 1c,d ). Another striking difference from the NB4 cells with FLT3-wt was that the Mcl-1 level did not change in response to IR (Fig. 1d) . Furthermore, MV4-11 responded to IR with increased protein levels of p53, Bax, Bcl-2, (Fig. 1d ) and p21 (data not shown) while the level of Bcl-X L was unaltered (data not shown). The IR induction of p53, Hdm2, Bax and p21 suggests that the p53 transcriptional activation in MV4-11 is intact [3] .
Attenuation of Hdm2 and Mcl-1 is independent of p53 and Flt3
The effect of IR was also examined in HL-60 cells, characterized by wild type FLT3 and deleted alleles for TP53 [22, 24] . Like inNB4 and MV4-11 cells, Hdm2 was attenuated and Flt3 increased, but the Flt3 protein appeared not to be full length ( Fig. 2a ; ~150 versus ~60 kDa). The lack of full length Flt3 was confirmed in cells from both ATCC and DSMZ within four passages of culture, and immunoprecipitation of Flt3 in these cells did not reveal any low molecular anti-Flt3 reactive form (data not shown). Flt3 protein has previously been reported non-detectable in HL-60 cells [26] .
Bcl-2 family members showed no significant response to IR in HL-60 cells except a late decrease in Mcl-1.
Human primary AML cells (patient 1) were irradiated and examined for Flt3 and Hdm2 modulation ( Fig. 2b) , indicating that the reciprocal Flt3-Hdm2 response to DNA damage also could be present in primary leukemia cells. In contrast to the HL-60 cells where the p21 response was absent, early increase was present in the primary AML cells. These differences reflects an absence of a p53 response in HL-60 cells and a presence of such in the patient cells (Fig. 2a,b ).
Daunorubicin induces attenuation of Hdm2 and Mcl-1 independent of TP53 and FLT3 status
Since both DNR and IR induce DNA damage, we examined the effect of DNR in both AML cell lines (NB4, MV4-11 and HL-60) and primary cells (patient 2). The cells were treated in vitro ( Fig. 3) with DNR for 5 hours at relevant concentrations [3] . The NB4 and MV4-11 cell lines were sensitive to DNR with regards to apoptosis induction, and both Mcl-1 and Hdm2 were down regulated (Fig. 3a) . Although DNR increased Flt3 protein in all the AML cells tested (Fig. 3ab) , this effect was most prominent in MV4-11 cells, HL-60 and the primary AML cells. HL-60 cells showed an increase in putative short forms of Flt3 protein with low doses of DNR (Fig. 3b) . 
Flt3 and Hdm2 protein are reciprocally regulated in vivo
We have recently demonstrated swift induction of p53 and Bax proteins in AML cells collected from patients undergoing induction chemotherapy with anthracyclines and cytarabine [3] . It was therefore of interest to examine the AML cells' protein levels of Flt3 and Hdm2 after in vivo chemotherapy (Fig. 4, one [25] . If Hdm2 regulates the turnover of Flt3 through ubiquitination, IRinduced Hdm2 degradation will result in elevated levels of Flt3. The observed down regulated Hdm2 in irradiated AML cells (Fig. 5) is probably due to proteasomal degradation [27, 28] . In addition to its ability of auto-ubiquitination, Hdm2 is ubiquitinated by several E3 ubiquitin ligases, including the p300-CBP associated factor (PCAF) and TSG101 [29, 30] . Future work is needed to address if modulation of Flt3 level may affect the level of Hdm2, and if this possible action is directly mediated by Flt3 on Hdm2 or involves other E3 ligases.
It can not be ruled out that the increase in Flt3 protein after IR is based on mechanisms independent of Hdm2. IR has been shown to increase the mRNA and protein lev- els of epidermal growth factor (EGF) receptor as well as the cell surface protein expression of IGF 1 receptor [31, 32] . Such mRNA regulation of Flt3 after IR was not observed in our study (Fig. 5) .
Induction therapy of AML reciprocally regulates Flt3 and Hdm2 proteins in vivo
The NB4 cells, in contrast to the MV4-11 cells, showed IR induced apoptosis (Fig. 5 ) and a lack of increase in HDM2 mRNA level. Since NB4 cells have non-functional p53 [33] , this suggests that NB4 undergoes a p53-independent apoptosis during IR-exposure. A possible explanation for the IR-resistance of MV4-11 is that AML cells with Flt3-ITD can repair double-stranded breaks in DNA more efficient than in cells with wild type Flt3 [13] , but an antiapoptotic effect on p53 by the MLL-fusion products may be an alternative mechanism [34] . This makes MV4-11 more protected against apoptosis induced by IR. Other explanations for early IR-induced apoptosis in NB4 cells in contrast to in the MV4-11 cells could include a proapoptotic response on the Bcl-2 family members and a lack of Hdm2 induction ( MV4-11 cells were resistant to IR while DNR effectively induced apoptosis (Fig. 5 ). DNR elicited a lasting Hdm2 and Mcl-1 down regulation in contrast to IR. This suggests that DNR ignites apoptosis through more pathways than IR and that the Mcl-1 attenuation is a pre-apoptotic event.
In addition to the induction of DNA damage, DNR is known to stimulate the level of the second messenger ceramide by de novo synthesis and thus trigger apoptosis [5] . Anthracyclines may also induce apoptosis via signalling through altered plasma membrane lipid rafts and the death receptor pathway [6] (for review see [7] ).
The p53-deficient HL-60 cell line demonstrated Hdm2 decrease as well as a putative Flt3 increase in response to IR or DNR (Fig. 5) . The FLT3 gene in HL-60 is wild type [24] , confirmed by sequencing of the juxtamembrane region and the kinase activation domain. Interestingly, lack of full length Flt3 protein in HL-60 has previously been reported [26] , and we were not able to detect full length Flt3 in different batches of HL-60 cells from ATCC and DMZS (Fig. 3b) . The protein bands between 50 and 100 kDa may be protein products from alternative splicing of FLT3 mRNA, as reported for the closely related platelet-derived growth factor alpha-receptor and KIT [35, 36] . Additional work is clearly needed to address the possibility of alternative splicing of FLT3 in HL-60 and in AML cells in general.
Flt3-ITD is the strongest predictor for relapse of AML in therapy with anthracyclines [12] , and is recently associated with enhanced DNA repair [13] . We demonstrated that the anti-apoptotic protein Bcl-2 was induced in MV4-11, HL-60 cells and primary AML cells during DNA damage therapy (Fig. 5 ). This could indicate that anthracyclines elicit an anti-apoptotic signal through Flt3. The anti-apoptotic signal may be particular strong in AML cells with a Flt3-ITD mutation including an Y591 duplication [14] .
Conclusion
In this study we show a concerted protein modulation of Flt3, Hdm2 and Mcl-1 after DNA damaging therapy in AML. IR resulted in decreased levels of Hdm2 and elevated levels of Flt3 and may involve p53 independent activities of Hdm2 acting on Flt3 as proposed for other receptor tyrosine kinases. The apoptotic response may depend on a persisting down regulation of Hdm2 and Mcl-1 [37] . Targeting of Flt3, Bcl-2/Bcl-X L and Mcl-1 is proposed to enhance the response of chemotherapy. Preclinical studies and early clinical trials that follow these principles are underway [38, 39] , and we believe that relevant biomarker examinations [3] including the proteins presented in this study may help to pinpoint the patients that will benefit from this enhanced therapy.
Methods
Cell culture
All patient studies were approved by the local ethical committee (REK Vest) and the Data Inspectorate, Norway. REK Vest is affiliated with the University of Bergen and Haukeland University Hospital. Samples were collected after informed consent. Patient data is overviewed in Table 1 .
Leukemic peripheral blood mononuclear cells (PBMC) were isolated by density gradient separation (FicollHypaque; Nycomed, Oslo, Norway) and were stored frozen in liquid nitrogen [40] . The percentage of blasts among leukemic PBMC exceeded 95% for all patients as judged by light microscopy of May-Grünwald-Giemsa stained cytospin smears [41] . PBMC were cultured in serum free conditions in StemSpan (Stem Cell Technologies, Vancouver, BC, Canada) at an average concentration of 2 × 10 6 cells per ml. Cells collected from patients during therapy followed the procedures as described by Anensen et al. 2006 [3] . 
Irradiation and chemotherapy treatment of cells
For irradiation induced DNA double strand breaks, samples were exposed to 25 Gray (Gy) from a Ce 137 source [11] and maintained in culture until samples were collected for Western blot analysis at time indicated. To secure that the observed effect was from the irradiation, the control samples were handled the same way as the exposed samples except for the actual irradiation. Collection of cells from AML patients under therapy and in vitro treatment of cells with daunorubicin was performed as previously described [3] .
Apoptosis assays
Cells were fixed in 2% paraformaldehyde solution containing the DNA specific nuclear stain Hoechst (Hoechst 33342, Invitrogen, Carlsbad, CA, USA; 10 µg/ml) and examined as previously described [33] . The number of normal and apoptotic nuclei was counted in an inverse fluorescence microscope (×400 magnification; Leica IRB, Leica Microsystems GmbH, Wetzlar, Germany). The mean number of three experiments was calculated together with the standard error of mean (standard deviation/√number of experiments). Nuclear staining with Hoechst of the cells treated with daunorubicin was not possible due to the strong fluorescence from the drug. These cells were fixed in 4% paraformaldehyde solution and their forward scatter and side scatter properties were examined by flow cytometry and used to determine the number of living cells. Flow cytometry was performed on a FacsCalibur flow cytometer (BD Biosciences, San Jose, CA, USA) and data analyses were carried out using the FlowJo software (Tree Star, Inc., Ashland, OR, USA).
Western blotting
Samples for Western blotting were prepared by pelleting the cells (3-10 millions) and washing them twice in 0.9% NaCl following lysis in the following buffer: 10 mM Tris (pH 7.5), 1 mM EDTA, 400 mM NaCl, 10% glycerol, 0.5% NP40, 5 mM NaF, 0.5 mM sodium orthovanadate, 1 mM DTT, and 0.1 mM PMSF (50-200 µl lysis buffer per sample) and transfered to 1.5 ml tubes. The samples were homogenized by 20 strokes of a plastic mini homogenizer before centrifugation at 14000 × g for 20 minutes. Protein concentrations were determined using the Bradford protein assay, following the manufacturers instructions (BioRad Laboratories, Inc., Hercules, CA, USA The patients were randomly selected; their clinical and biological data are included as background information.
antibody AC-15 was from Abcam plc, Cambridge, UK and the Hdm2 antibodies 2A10 and IF2 were from Calbiochem, San Diego, CA, USA.
Secondary antibodies conjugated to horse radish peroxidase (Jackson ImmunoResearch laboratories, West Grove, PA, USA) were diluted in 4% fat-free dry milk in TBSTween and incubated 1 hour at room temperature. After washing for 1 hour with TBS-Tween, the membranes were developed using Supersignal ® West Pico or West Femto Chemiluminiscence Substate from Pierce Biotechnology Inc, Rockford, IL, USA according to the manufacturers' instructions. The membranes were imaged using a Kodak Image Station 2000R (Eastman Kodak Co., Lake Avenue, Rochester, NY, USA), and bands were quantified using the Kodak analysis software. Data were exported to Excel spreadsheet, corrected for background and loading control intensities and a Student's two-tailed t test was used for determination of significance.
Real time PCR
Immediately after in vitro experiments, 5 × 10 6 cells were dissolved in RNAlater (Ambion Inc.) to stabilize and protect RNA and then stored at -80°C. RNAeasy plus mini kit (Qiagen Inc.) was used for isolation of total RNA. Cells were thawed, centrifuged and resuspended in RTL buffer and further procedures were followed according to manufacturer's instructions. RNA quality was tested on a 2100 Bioanalyzer (Agilent Technologies) and total RNA was quantified with a spectrophotometer for small aliquots (NanoDrop Technologies, Wilmington, DE, USA). cDNA were synthesized using the High-Capasity cDNA Archive Kit (Applied Biosystems, Foster City, CA) running 625 ng RNA in 50 µl total reaction volume. Real Time PCR was performed using assays-on-demand containing primers and FAM dye-labelled probes. Human GAPDH and β-Actin were used as endogenous controls. For Flt3 and Hdm2, assays Hs00174690_m1 and Hs00234753_m1 (Applied Biosystems) were used. TaqMan Universal PCR Master Mix (Applied Biosystems) was run with 2 µl cDNA in 10 µl total reaction volumes. The PCR was performed in a 384-well clear optical reaction plate on a 7900HT real time PCR system (Applied Biosystems). The calibrator sample in each experiment was used for standard curve dilution. All samples were run in three replicates and data were analyzed using the relative standard curve method as described by the manufacturer (Applied Biosystems).
